Back to Search
Start Over
Saniona plans initiation of a phase 2a study with Tesomet for treatment of hypothalamic obesity
- Source :
- M2 Pharma. June 12, 2018
- Publication Year :
- 2018
-
Abstract
- M2 PHARMA-June 12, 2018-Saniona plans initiation of a phase 2a study with Tesomet for treatment of hypothalamic obesity (C)2018 M2 COMMUNICATIONS Biotechnology company Saniona AB (STO:SANION) announced on Monday that [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Pharma
- Publication Type :
- News
- Accession number :
- edsgcl.542246607